476 related articles for article (PubMed ID: 27286788)
1. Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.
Ossa CA; Torres D
Oncologist; 2016 Jul; 21(7):832-9. PubMed ID: 27286788
[TBL] [Abstract][Full Text] [Related]
2. High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Torres D; Rashid MU; Gil F; Umana A; Ramelli G; Robledo JF; Tawil M; Torregrosa L; Briceno I; Hamann U
Breast Cancer Res Treat; 2007 Jun; 103(2):225-32. PubMed ID: 17080309
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.
Weitzel JN; Lagos V; Blazer KR; Nelson R; Ricker C; Herzog J; McGuire C; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1666-71. PubMed ID: 16030099
[TBL] [Abstract][Full Text] [Related]
4.
Alvarez C; Tapia T; Perez-Moreno E; Gajardo-Meneses P; Ruiz C; Rios M; Missarelli C; Silva M; Cruz A; Matamala L; Carvajal-Carmona L; Camus M; Carvallo P
Oncotarget; 2017 Sep; 8(43):74233-74243. PubMed ID: 29088781
[TBL] [Abstract][Full Text] [Related]
5. Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado.
Mullineaux LG; Castellano TM; Shaw J; Axell L; Wood ME; Diab S; Klein C; Sitarik M; Deffenbaugh AM; Graw SL
Cancer; 2003 Aug; 98(3):597-602. PubMed ID: 12879478
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
Alemar B; Herzog J; Brinckmann Oliveira Netto C; Artigalás O; Schwartz IVD; Matzenbacher Bittar C; Ashton-Prolla P; Weitzel JN
Cancer Genet; 2016 Sep; 209(9):417-422. PubMed ID: 27425403
[TBL] [Abstract][Full Text] [Related]
7. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
Hamel N; Kotar K; Foulkes WD
BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.
Dutil J; Golubeva VA; Pacheco-Torres AL; Diaz-Zabala HJ; Matta JL; Monteiro AN
Breast Cancer Res Treat; 2015 Dec; 154(3):441-53. PubMed ID: 26564481
[TBL] [Abstract][Full Text] [Related]
9. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
10. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.
Akbari MR; Donenberg T; Lunn J; Curling D; Turnquest T; Krill-Jackson E; Zhang S; Narod SA; Hurley J
Clin Genet; 2014 Jan; 85(1):64-7. PubMed ID: 23458327
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Rodríguez AO; Llacuachaqui M; Pardo GG; Royer R; Larson G; Weitzel JN; Narod SA
Gynecol Oncol; 2012 Feb; 124(2):236-43. PubMed ID: 22044689
[TBL] [Abstract][Full Text] [Related]
13. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.
Takano EA; Mitchell G; Fox SB; Dobrovic A
BMC Cancer; 2008 Feb; 8():59. PubMed ID: 18298804
[TBL] [Abstract][Full Text] [Related]
15. A high proportion of founder BRCA1 mutations in Polish breast cancer families.
Górski B; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Grzybowska E; Mackiewicz A; Stawicka M; Bebenek M; Sorokin D; Fiszer-Maliszewska Ł; Haus O; Janiszewska H; Niepsuj S; Góźdź S; Zaremba L; Posmyk M; Płuzańska M; Kilar E; Czudowska D; Waśko B; Miturski R; Kowalczyk JR; Urbański K; Szwiec M; Koc J; Debniak B; Rozmiarek A; Debniak T; Cybulski C; Kowalska E; Tołoczko-Grabarek A; Zajaczek S; Menkiszak J; Medrek K; Masojć B; Mierzejewski M; Narod SA; Lubiński J
Int J Cancer; 2004 Jul; 110(5):683-6. PubMed ID: 15146557
[TBL] [Abstract][Full Text] [Related]
16. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update.
Szwiec M; Jakubowska A; Górski B; Huzarski T; Tomiczek-Szwiec J; Gronwald J; Dębniak T; Byrski T; Kluźniak W; Wokołorczyk D; Birkenfeld B; Akbari MR; Narod SA; Lubiński J; Cybulski C
Clin Genet; 2015 Mar; 87(3):288-92. PubMed ID: 24528374
[TBL] [Abstract][Full Text] [Related]
17. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Tonin PN
Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 and BRCA2 screening of nine Chilean founder mutations through allelic-discrimination and real-time PCR in breast/ovarian cancer patients.
Alvarez C; Ortega-Hernández V; Cortez A; Carvallo P
Mol Biol Rep; 2022 Aug; 49(8):7531-7539. PubMed ID: 35596815
[TBL] [Abstract][Full Text] [Related]
19. Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.
Jara L; Morales S; de Mayo T; Gonzalez-Hormazabal P; Carrasco V; Godoy R
Biol Res; 2017 Oct; 50(1):35. PubMed ID: 28985766
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
